Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.6 USD | +0.80% |
|
-1.43% | +11.27% |
07-01 | Raymond James Initiates AxoGen at Outperform With $13 Price Target | MT |
06-24 | Axogen, Inc. Announces Full Launch of Avive+ Soft Tissue Matrix | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.27% | 330M | |
+1.04% | 206B | |
+3.96% | 177B | |
+31.77% | 157B | |
+31.66% | 112B | |
+1.56% | 64.63B | |
+20.45% | 55.63B | |
-3.54% | 47.57B | |
-9.32% | 36.87B | |
-1.25% | 35.18B |
- Stock Market
- Equities
- AXGN Stock
- News AxoGen, Inc.
- Transcript : AxoGen, Inc. Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-16-2020 10